Abstract
The World Health Organization has declared obesity to be a global epidemic that increases cardiovascular disease (CVD) mortality risk factors, such as hypertension, diabetes, dyslipidemia, and atherosclerosis. The increasing ratio of time spent in sedentary activities to that spent performing physically demanding tasks increases the trends to obesity and susceptibility to these risk factors. Dyslipidemia is the foundation of atherosclerotic buildup and lipoproteins serve as cofactors to the inflammatory processes that destabilize plaques. Increasing cardiorespiratory fitness and muscular strength helps attenuate concentrations of low-density lipoproteins (LDLs), such as LDL cholesterol, and increase levels of high-density lipoprotein cholesterol, as well as reduce proprotein convertase subtilisin kexin type 9 expression. Effects of physical activity on the inflammatory pathways of atherosclerosis, specifically C-reactive protein, are more closely related to reducing the levels of adiposity in tandem with increasing fitness, than with exercise training alone. The purpose of this review is to describe the physiology of dyslipidemia and relate it to CVD and exercise therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Goff DC Jr, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY et al (2006) Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation 113:647–656
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R et al (2017) Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation 135:e146–e603
Fletcher GF, Landolfo C, Niebauer J, Ozemek C, Arena R, Lavie CJ (2018) Promoting physical activity and exercise: JACC health promotion series. J Am Coll Cardiol 72:1622–1639
Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM et al (2011) American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 43:1334–1359
Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA et al (2018) The physical activity guidelines for Americans. JAMA 320:2020–2028
Caspersen CJ, Powell KE, Christenson GM (1985) Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 100:126–131
Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847
Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM et al (2006) Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295:1556–1565
Anderson KM, Castelli WP, Levy D (1987) Cholesterol and mortality: 30 years of follow-up from the Framingham study. JAMA 257:2176–2180
Ference BA, Graham I, Tokgozoglu L, Catapano AL (2018) Impact of lipids on cardiovascular health: JACC health promotion series. J Am Coll Cardiol 72:1141–1156
Lavie CJ, Church TS, Milani RV, Earnest CP (2011) Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev 31:137–145
Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J et al (2005) Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 352:29–38
Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH et al (2005) C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352:20–28
Morrow DA, de Lemos JA, Sabatine MS, Wiviott SD, Blazing MA, Shui A et al (2006) Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor trial. Circulation 114:281–288
Kones R (2010) Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective. Drug Des Devel Ther 4:383–413
Cicoira M, Zanolla L, Franceschini L, Rossi A, Golia G, Zamboni M et al (2001) Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. J Am Coll Cardiol 37:2080–2085
Lavie CJ, Ozemek C, Carbone S, Katzmarzyk PT, Blair SN (2019) Sedentary behavior, exercise, and cardiovascular health. Circ Res 124:799–815
Lavie CJ, Kachur S, Sui X (2019) Impact of fitness and changes in fitness on lipids and survival. Prog Cardiovasc Dis 62:431–435
Swift DL, Lavie CJ, Johannsen NM, Arena R, Earnest CP, O'Keefe JH et al (2013) Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J 77:281–292
Mora S, Redberg RF, Cui Y, Whiteman MK, Flaws JA, Sharrett AR et al (2003) Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA 290:1600–1607
Katzmarzyk PT, Church TS, Blair SN (2004) Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Arch Intern Med 164:1092–1097
Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M et al (2009) Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 301:2024–2035
Blair SN, Kampert JB, Kohl HW 3rd, Barlow CE, Macera CA, Paffenbarger RS Jr et al (1996) Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA 276:205–210
Lyerly GW, Sui X, Lavie CJ, Church TS, Hand GA, Blair SN (2009) The association between cardiorespiratory fitness and risk of all-cause mortality among women with impaired fasting glucose or undiagnosed diabetes mellitus. Mayo Clin Proc 84:780–786
Lee D, Sui X, Artero EG, Lee IM, Church TS, McAuley PA et al (2011) Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men: the aerobics center longitudinal study. Circulation 124:2483–2490
Kokkinos PF, Faselis C, Myers J, Panagiotakos D, Doumas M (2013) Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study. Lancet 381:394–399
Kawano M, Shono N, Yoshimura T, Yamaguchi M, Hirano T, Hisatomi A (2009) Improved cardio-respiratory fitness correlates with changes in the number and size of small dense LDL: randomized controlled trial with exercise training and dietary instruction. Intern Med 48:25–32
Arsenault BJ, Lachance D, Lemieux I, Alméras N, Tremblay A, Bouchard C et al (2007) Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome. Arch Intern Med 167:1518–1525
Batacan RB Jr, Duncan MJ, Dalbo VJ, Tucker PS, Fenning AS (2017) Effects of high-intensity interval training on cardiometabolic health: a systematic review and meta-analysis of intervention studies. Br J Sports Med 51:494–503
Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA et al (2007) Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 39:1423–1434
Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS et al (2002) Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347:1483–1492
Crouse SF, O’Brien BC, Grandjean PW, Lowe RC, Rohack JJ, Green JS et al (1985) (1997) training intensity, blood lipids, and apolipoproteins in men with high cholesterol. J Appl Physiol Bethesda Md 82:270–277
O’Donovan G, Owen A, Bird SR, Kearney EM, Nevill AM, Jones DW et al (2005) Changes in cardiorespiratory fitness and coronary heart disease risk factors following 24 wk of moderate- or high-intensity exercise of equal energy cost. J Appl Physiol 98:1619–1625
Ozemek C, Laddu DR, Lavie CJ, Claeys H, Kaminsky LA, Ross R et al (2018) An update on the role of cardiorespiratory fitness, structured exercise and lifestyle physical activity in preventing cardiovascular disease and health risk. Prog Cardiovasc Dis 61:484–490
Kelley G, Kelley K, Tran ZV (2005) Aerobic exercise, lipids and lipoproteins in overweight and obese adults: a meta-analysis of randomized controlled trials. Int J Obes 29:881–893
Kujala UM, Jokelainen J, Oksa H, Saaristo T, Rautio N, Moilanen L et al (2011) Increase in physical activity and cardiometabolic risk profile change during lifestyle intervention in primary healthcare: 1-year follow-up study among individuals at high risk for type 2 diabetes. BMJ Open 1:e000292. https://doi.org/10.1136/bmjopen-2011-000292
Bakker EA, Lee D, Sui X, Eijsvogels TMH, Ortega FB, Lee IM et al (2018) Association of Resistance Exercise with the incidence of hypercholesterolemia in men. Mayo Clin Proc 93:419–428
Artero EG, Lee D, Lavie CJ, España-Romero V, Sui X, Church TS et al (2012) Effects of muscular strength on cardiovascular risk factors and prognosis. J Cardiopulm Rehabil Prev 32:351–358
Kaminsky LA, Arena R, Ellingsen Ø, Harber MP, Myers J, Ozemek C et al (2019) Cardiorespiratory fitness and cardiovascular disease - the past, present, and future. Prog Cardiovasc Dis 62:86–93
Liu Y, Lee DC, Li Y, Zhu W, Zhang R, Sui X et al (2019) Associations of resistance exercise with cardiovascular disease morbidity and mortality. Med Sci Sports Exerc 51:499–508
Schroeder EC, Franke WD, Sharp RL, Lee D (2019) Comparative effectiveness of aerobic, resistance, and combined training on cardiovascular disease risk factors: a randomized controlled trial. PLoS One 14:e0210292. https://doi.org/10.1371/journal.pone.0210292
Blair SNB, Cooper K, Gibbons L, Gettman LR, Lewis S, Goodyear N (1983) Changes in coronary heart disease risk factors associated with increased treadmill time in 753 men. Am J Epidemiol 118:352–359
Sui X, Sarzynski MA, Lee DC, Kokkinos PF (2017) Impact of changes in cardiorespiratory fitness on hypertension, dyslipidemia and survival: an overview of the epidemiological evidence. Prog Cardiovasc Dis 60:56–66
Parto P, Lavie CJ, Swift D, Sui X (2015) The role of cardiorespiratory fitness on plasma lipid levels. Expert Rev Cardiovasc Ther 13:1177–1183
Lee DC, Sui X, Church TS, Lavie CJ, Jackson AS, Blair SN (2012) Changes in fitness and fatness on the development of cardiovascular disease risk factors hypertension, metabolic syndrome, and hypercholesterolemia. J Am Coll Cardiol 59:665–672
Breneman CB, Polinski K, Sarzynski MA, Lavie CJ, Kokkinos PF, Ahmed A et al (2016) The impact of cardiorespiratory fitness levels on the risk of developing Atherogenic dyslipidemia. Am J Med 129:1060–1066
Lavie CJ, Milani RV (1994) Effects of cardiac rehabilitation and exercise training on low-density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease. Am J Cardiol 74:1192–1195
Lavie CJ, Milani RV (1996) Effects of nonpharmacologic therapy with cardiac rehabilitation and exercise training in patients with low levels of high-density lipoprotein cholesterol. Am J Cardiol 78:1286–1289
Tall AR (2002) Exercise to reduce cardiovascular risk--how much is enough? N Engl J Med 347:1522–1524
Park YM, Sui X, Liu J, Zhou H, Kokkinos PF, Lavie CJ et al (2015) The effect of cardiorespiratory fitness on age-related lipids and lipoproteins. J Am Coll Cardiol 65:2091–2100
Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB et al (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. J Am Coll Cardiol 44:720–732
Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K (1998) Prevention of coronary heart disease in clinical practice: recommendations of the second joint task force of European and other societies on coronary prevention. Atherosclerosis 140:199–270
Zaleski AL, Mentch ML, Pescatello LS, Taylor BA, Capizzi JA, Grimaldi AS et al (2014) Effects of atorvastatin on resting and peak exercise blood pressure among normotensive men and women. Cholesterol 2014:720507. https://doi.org/10.1155/2014/720507
Khush KK, Waters D (2004) Lessons from the PROVE-IT trial. Higher dose of potent statin better for high-risk patients. Cleve Clin J Med 71:609–616
Durstine JL, Grandjean PW, Cox CA, Thompson PD (2002) Lipids, lipoproteins, and exercise. J Cardpulm Rehabil 22:385–398
Kelley GA, Kelley KS (2006) Aerobic exercise and HDL2-C: a meta-analysis of randomized controlled trials. Atherosclerosis 184:207–215
Wosornu D, Bedford D, Ballantyne D (1996) A comparison of the effects of strength and aerobic exercise training on exercise capacity and lipids after coronary artery bypass surgery. Eur Heart J 17:854–863
Yu CM, Li LS, Ho HH, Lau CP (2003) Long-term changes in exercise capacity, quality of life, body anthropometry, and lipid profiles after a cardiac rehabilitation program in obese patients with coronary heart disease. Am J Cardiol 91:321–325
Wilhelmsen L, Sanne H, Elmfeldt D, Grimby G, Tibblin G, Wedel H (1975) A controlled trial of physical training after myocardial infarction. Effects on risk factors, nonfatal reinfarction, and death. Prev Med 4:491–508
Marti B, Suter E, Riesen WF et al (1990) Effects of long-term, self-monitored exercise on the serum lipoprotein and apolipoprotein profile in middle-aged men. Atherosclerosis 81:19–31
Belardinelli R, Paolini I, Cianci G, Piva R, Georgiou D, Purcaro A (2001) Exercise training intervention after coronary angioplasty: the ETICA trial. J Am Coll Cardiol 37:1891–1900
Després JP, Moorjani S, Tremblay A, Poehlman ET, Lupien PJ, Nadeau A et al (1988) Heredity and changes in plasma lipids and lipoproteins after short-term exercise training in men. Arterioscler Dallas Tex 8:402–409
Church TS, LaMonte MJ, Barlow CE, Blair SN (2005) Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. Arch Intern Med 165:2114–212063
Halverstadt A, Phares DA, Wilund KR et al (2007) Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women. Metabolism 56:444–450
Stevens J, Cai J, Evenson KR, Thomas R (2002) Fitness and fatness as predictors of mortality from all causes and from cardiovascular disease in men and women in the lipid research clinics study. Am J Epidemiol 156:832–841
Lee CD, Blair SN, Jackson AS (1999) Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J ClinNutr 69:373–380
Tambalis K, Panagiotakos DB, Kavouras SA, Sidossis LS (2009) Responses of blood lipids to aerobic, resistance, and combined aerobic with resistance exercise training: a systematic review of current evidence. Angiology 60:614–632. https://doi.org/10.1177/0003319708324927
Pascot A, Lemieux I, Prud'homme D, Tremblay A, Nadeau A, Couillard C et al (2001) Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 42:2007–2014
Madsen C, Varbo A, Nordestgaard B (2017) Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J 38:2478–2486
Ko DT, Alter DA, Guo H et al (2016) High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions: the CANHEART study. J Am Coll Cardiol 68:2073–2083
Bowe B, Xie Y, Xian H, Balasubramanian S, Zayed MA, Al-Aly Z (2016) High density lipoprotein cholesterol and the risk of all-cause mortality among U.S. veterans. Clin J Am SocNephrol 11:1784–1793
Li C, Ford ES, Meng YX, Mokdad AH, Reaven GM (2008) Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovasc Diabetol 7:4. https://doi.org/10.1186/1475-2840-7-4
Vaara JP, Fogelholm M, Vasankari T, Santtila M, Häkkinen K, Kyröläinen H (2014) Associations of maximal strength and muscular endurance with cardiovascular risk factors. Int J Sports Med 35:356–360
Lavie CJ, Thomas RJ, Squires RW, Allison TG, Milani RV (2009) Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin Proc 84:373–383
Salehi Z, Salehi K, Moeini M, Kargarfard M, Sadeghi M (2017) The effect of resistance exercise on lipid profile of coronary artery disease patients: a randomized clinical trial. Iran J Nurs Midwifery Res 22:112–116
Braith RW, Stewart KJ (2006) Resistance exercise training. Circulation 113:2642–2650
Wolska A, Dunbar RL, Freeman LA, Ueda M, Amar MJ, Sviridov DO et al (2017) Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism. Atherosclerosis 267:49–60
Thompson PD (1990) What do muscles have to do with lipoproteins? Circulation 81:1428–1430
Nicklas BJ, Katzel LI, Busby-Whitehead J, Goldberg AP (1997) Increases in high-density lipoprotein cholesterol with endurance exercise training are blunted in obese compared with lean men. Metabolism 46:556–561
Bergeron J, Couillard C, Després JP, Gagnon J, Leon AS, Rao DC et al (2001) Race differences in the response of postheparin plasma lipoprotein lipase and hepatic lipase activities to endurance exercise training in men: results from the HERITAGE family study. Atherosclerosis 159:399–406
Jong M, Hofker MH, Havekes LM (1999) Role of ApoCs in lipoprotein metabolism. Arterioscler Thromb Vasc Biol 19:472–484
Nye ER, Carlson K, Kirstein P, Rössner S (1981) Changes in high density lipoprotein subfractions and other lipoproteins by exercise. Clin Chim Acta Int J Clin Chem 113:51–57
Després JP, Pouliot MC, Moorjani S, Nadeau A, Tremblay A, Lupien PJ et al (1991) Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Phys 261:E159–E167
Gordon PM, Visich PS, Goss FL, Fowler S, Warty V, Denys BJ et al (1996) Comparison of exercise and normal variability on HDL cholesterol concentrations and lipolytic activity. Int J Sports Med 17:332–337
Mann S, Beedie C, Jimenez A (2014) Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Med 44:211–221
Ferguson MA, Alderson NL, Trost SG, Essig DA, Burke JR, Durstine JL (1998) Effects of four different single exercise sessions on lipids, lipoproteins, and lipoprotein lipase. J Appl Physiol 85:1169–1174
Tsimikas S, Duff GW, Berger PB, Rogus J, Huttner K, Clopton P et al (2014) Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a). J Am Coll Cardiol 63:1724–1734
Rawther T, Tabet F (2019) Biology, pathophysiology and current therapies that affect lipoprotein (a) levels. J Mol Cell Cardiol 131:1–11
Dangas G, Mehran R, Harpel PC, Sharma SK, Marcovina SM, Dube G et al (1998) Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. J Am Coll Cardiol 32:2035–2042
van Dijk RA, Kolodgie F, Ravandi A, Leibundgut G, Hu PP, Prasad A et al (2012) Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions. J Lipid Res 53:2773–2790
Krychtiuk KA, Kastl SP, Hofbauer SL, Wonnerth A, Goliasch G, Ozsvar-Kozma M et al (2015) Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a). J Clin Lipidol 9:533–541
Rogacev KS, Cremers B, Zawada AM, Seiler S, Binder N, Ege P et al (2012) CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol 60:1512–1520
Rocco DDFM, Okuda LS, Pinto RS, Ferreira FD, Kubo SK, Nakandakare ER et al (2011) Aerobic exercise improves reverse cholesterol transport in cholesteryl ester transfer protein transgenic mice. Lipids 46:617–625
Kamani CH, Gencer B, Montecucco F, Courvoisier D, Vuilleumier N, Meyer P et al (2015) Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population. Eur J Clin Investig 45:1017–1024
Wang Y, Xu D (2017) Effects of aerobic exercise on lipids and lipoproteins. Lipids Health Dis 16:132. https://doi.org/10.1186/s12944-017-0515-5
Pedersen BK, Febbraio MA (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88:1379–1406
Selvin E, Paynter NP, Erlinger TP (2007) The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 167:31–39
Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ et al (2008) The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med 5:621–635
Lavie CJ, Milani RV, Verma A, O’Keefe JH (2009) C-reactive protein and cardiovascular diseases--is it ready for primetime? Am J Med Sci 338(6):486–492
Mohamed-Ali V, Pinkney J, Coppack S (1998) Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 22:1145–1158
Flier JS (1995) The adipocyte: storage depot or node on the energy information superhighway? Cell 80:15–18
Visser M, Bouter L, McQuillan G, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131–2135
Mora S, Lee I-M, Buring JE, Ridker PM (2006) Association of Physical Activity and Body Mass Index with Novel and traditional cardiovascular biomarkers in women. JAMA 295:1412. https://doi.org/10.1001/jama.295.12.1412
Albert MA, Glynn RJ, Ridker PM (2004) Effect of physical activity on serum C-reactive protein. Am J Cardiol 93:221–225
Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Rimm EB (2003) Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. Obes Res 11:1055–1064
Stauffer BL, Hoetzer GL, Smith DT, DeSouza CA (2004) Plasma C-reactive protein is not elevated in physically active postmenopausal women taking hormone replacement therapy. J Appl Physiol (1985) 96:143–148
Geffken DF, Cushman M, Burke GL, Polak JF, Sakkinen PA, Tracy RP (2001) Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 153:242–250
LaMonte MJ, Durstine LJ, Yanowitz FG, Lim T, DuBose KD, Davis P et al (2002) Cardiorespiratory fitness and C-reactive protein among a tri-ethnic sample of women. Circulation 106:403–406
Valentine RJ, Vieira VJ, Woods JA, Evans EM (2009) Stronger relationship between central adiposity and C-reactive protein in older women than men. Menopause 16:84–89
Lakka TA, Lakka HM, Rankinen T, Leon AS, Rao DC, Skinner JS et al (2005) Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE family study. Eur Heart J 26:2018–2025
Fedewa MV, Hathaway ED, Ward-Ritacco CL (2017) Effect of exercise training on C reactive protein: a systematic review and meta-analysis of randomised and non-randomised controlled trials. Br J Sports Med 51:670–676
Church TS, Earnest CP, Thompson AM, Priest EL, Rodarte RQ, Saunders T et al (2010) Exercise without weight loss does not reduce C-reactive protein: the INFLAME study. Med Sci Sports Exerc 42:708–716
Hammonds TL, Gathright EC, Goldstein CM, Penn MS, Hughes JW (2016) Effects of exercise on c-reactive protein in healthy patients and in patients with heart disease: a meta-analysis. Heart Lung J Crit Care 45:273–282
Lavie CJ, Morshedi-Meibodi A, Milani RV (2008) Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients. J Cardiometab Syndr 3:136–140
Lavie CJ, Milani RV, Artham SM, Lavie CJ, Milani RV, Artham SM, Patel DA, Ventura HO (2009) The obesity paradox, weight loss, and coronary disease. Am J Med 122:1106–1114
Ruiz JR, Ortega FB, Wärnberg J, Moreno LA, Carrero JJ, Gonzalez-Gross M et al (2008) Inflammatory proteins and muscle strength in adolescents: the Avena study. Arch Pediatr Adolesc Med 162:462–468
Sardeli AV, Tomeleri CM, Cyrino ES, Fernhall B, Cavaglieri CR, Chacon-Mikahil MPT (2018) Effect of resistance training on inflammatory markers of older adults: a meta-analysis. Exp Gerontol 111:188–196
Ramel A, Geirsdottir OG, Jonsson PV, Thorsdottiri I (2015) C-reactive protein and resistance exercise in community dwelling old adults. J Nutr Health Aging 19:792–796
Church TS, Blair SN, Cocreham S, Johannsen N, Johnson W, Kramer K et al (2010) Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes. J Am Med Assoc 304:2253–2262
Swift DL, Johannsen NM, Earnest CP, Blair SN, Church TS (2012) The effect of exercise training modality on C-reactive protein in Type-2 diabetes. Med Sci Sports Exerc 44:1028–1034
Donges CE, Duffield R, Drinkwater EJ (2010) Effects of resistance or aerobic exercise training on interleukin-6, C-reactive protein, and body composition. Med Sci Sports Exerc 42:304–313
Lee JS, Kim CG, Seo TB, Kim HG, Yoon SJ (2015) Effects of 8-week combined training on body composition, isokinetic strength, and cardiovascular disease risk factors in older women. Aging Clin Exp Res 27:179–186
Mavros Y, Kay S, Simpson KA, Baker MK, Wang Y, Zhao RR et al (2014) Reductions in C-reactive protein in older adults with type 2 diabetes are related to improvements in body composition following a randomized controlled trial of resistance training. J Cachexia Sarcopenia Muscle 5:111–120
Swift DL, Nevels TR, Landrine H, Lavie CJ, Newton RL, Das BM et al (2017) Abstract 32: racial differences in cardiorespiratory fitness between African and Caucasian Americans: a meta-analysis. Circulation 135:A32
Saffer H, Dave D, Grossman M, Leung LA (2013) Racial, ethnic, and gender differences in physical activity. J Hum Cap 7:378–410
Centers for Disease Control and Prevention (2019) QuickStats: percentage of adults who met Federal Guidelines for aerobic physical activity through leisure-time activity, by race/ethnicity—National Health Interview Survey, 2008–2017. MMWR Morb Mortal Wkly Rep 68:292. https://doi.org/10.15585/mmwr.mm6812a6
Centers for Disease Control and Prevention (2016) QuickStats: Percentage of U.S. Adults Who Met the 2008 Federal Physical Activity Guidelines for Aerobic and Strengthening Activity, by Sex—National Health Interview Survey, 2000–2014. MMWR Morb Mortal Wkly Rep 65:485. https://doi.org/10.15585/mmwr.mm6518a9
Centers for Disease Control and Prevention (2016) QuickStats: percentage of adults who met Federal Guidelines for aerobic physical activity, by poverty status — National Health Interview Survey, United States, 2014. MMWR Morb Mortal Wkly Rep 65:459. https://doi.org/10.15585/mmwr.mm6517a6
WHO|What is Moderate-intensity and Vigorous-intensity Physical Activity? In: WHO. https://www.who.int/dietphysicalactivity/physical_activity_intensity/en/. Accessed 12 Aug 2020
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Mendoza, M.V.F., Kachur, S.M., Lavie, C.J. (2022). The Effects of Exercise on Lipid Biomarkers. In: Guest, P.C. (eds) Physical Exercise and Natural and Synthetic Products in Health and Disease. Methods in Molecular Biology, vol 2343. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1558-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1558-4_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1557-7
Online ISBN: 978-1-0716-1558-4
eBook Packages: Springer Protocols